Article Details
Retrieved on: 2018-02-26 18:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>In a deal that didn't create too many ripples then, KKR India, the domestic arm of global investment giant <b>Kohlberg Kravis Roberts</b> & Co., invested $200 million (Rs 1,263 crore at today's exchange rate) in a Hyderabad-based generic pharmaceutical products company called Gland Pharma. It was just ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here